SELLAS Life Sciences SLS
NASDAQ SLS
$11.74 +0.41 (+3.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Asset Writedowns and Impairment (2017)

Updated

SELLAS Life Sciences' Asset Writedowns and Impairment was $5.7 million in FY2021.

Analysis

SELLAS Life Sciences (SLS) Asset Writedowns and Impairment (2017) Analysis & Trends

From FY2015 onward, SELLAS Life Sciences has reported Asset Writedowns and Impairment for 4 years.

  • Asset Writedowns and Impairment shows a three-year compound annual growth rate of -14.4% (FY2018 to FY2021).
  • The FY2021 figure marks the highest annual Asset Writedowns and Impairment since FY2018.
  • Per Business Quant data, Asset Writedowns and Impairment in earlier years was $2.83 million in FY2019 (-68.9%) and $9.1 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 SELLAS Life Sciences 2.37 Bn 2.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -3.56 Mn
Sep 30, 2017 512,000.00
API Access

SELLAS Life Sciences Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SLS&period=max&api_key=YOUR_API_KEY